Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives

Published:2022-03 Issue: Volume:232 Page:114176
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Lele,Zhang Jifa,Wang Jiaxing,Ren Changyu,Tang Pan,Ouyang Liang,Wang Yuxi

Funder

Sichuan Province Science and Technology Support Program

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference141 articles.

1. Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides;Villa;Cancers,2019

2. Adaptive reprogramming of de novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer;Brown;Cancer Discov.,2017

3. Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation;Dimitrova;J. Immunol.,2002

4. A non-proliferative role of pyrimidine metabolism in cancer;Siddiqui;Mol. Metabol.,2020

5. Pyrimidine metabolism: dynamic and versatile pathways in pathogens and cellular development;Garavito;Journal of Genetics and Genomics,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of piperine derivatives as inhibitors of human dihydroorotate dehydrogenase to induce ferroptosis in cancer cells;Bioorganic Chemistry;2024-09

2. Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity;ChemMedChem;2024-08-06

3. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022);Recent Patents on Anti-Cancer Drug Discovery;2024-08

4. Metabolic Plasticity of Glioblastoma Cells in Response to DHODH Inhibitor BAY2402234 Treatment;Metabolites;2024-07-27

5. Inhibition of FSP1: A new strategy for the treatment of tumors (Review);Oncology Reports;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3